MedPath
HSA Approval

NAZOLIN NASAL SPRAY 0.05%

SIN10520P

NAZOLIN NASAL SPRAY 0.05%

NAZOLIN NASAL SPRAY 0.05%

December 8, 1998

PHARMATECH MEDICAL ENTERPRISE PTE LTD

PHARMATECH MEDICAL ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence HolderPHARMATECH MEDICAL ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SPRAY

NASAL

Medical Information

R01AA05

oxymetazoline

Manufacturer Information

PHARMATECH MEDICAL ENTERPRISE PTE. LTD.

BEXIMCO PHARMACEUTICALS LTD

Active Ingredients

OXYMETAZOLINE HCl

0.05%

Oxymetazoline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NAZOLIN NASAL SPRAY 0.05% - HSA Approval | MedPath